Short answer · Medically reviewed summary · Last updated: 2026-04-07
Rosai-Dorfman disease does not have a unique, dedicated code in the ICD-10 or ICD-9 systems, but is typically classified under the code D76.3 (Other histiocytosis) in ICD-10 and 288.4 (Hemophagocytic lymphohistiocytosis) or 289.9 (Unspecified disease of blood and blood-forming organs) in ICD-9. Because Rosai-Dorfman disease is a rare non-Langerhans cell histiocytosis, clinicians often use these broader categories to facilitate medical billing and documentation. What is the clinical classification of Rosai-Dorfman disease? Rosai-Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy, is a rare proliferative disorder of histiocytes.
Rosai-Dorfman disease does not have a unique, dedicated code in the ICD-10 or ICD-9 systems, but is typically classified under the code D76.3 (Other histiocytosis) in ICD-10 and 288.4 (Hemophagocytic lymphohistiocytosis) or 289.9 (Unspecified disease of blood and blood-forming organs) in ICD-9. Because Rosai-Dorfman disease is a rare non-Langerhans cell histiocytosis, clinicians often use these broader categories to facilitate medical billing and documentation.
Rosai-Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy, is a rare proliferative disorder of histiocytes. Because it is not a primary malignancy, it falls under the classification of histiocytic disorders. In the clinical setting, accurately coding Rosai-Dorfman disease is essential for tracking patient outcomes, though the lack of a specific ICD-10 code can sometimes lead to administrative challenges. Physicians often supplement the D76.3 code with additional diagnostic codes that reflect the specific involvement of extranodal sites, such as the skin, bone, or central nervous system, which occur in approximately 43% of cases.
Diagnosis of Rosai-Dorfman disease is primarily achieved through histopathological examination of biopsy tissue. The hallmark feature is "emperipolesis," where histiocytes contain intact lymphocytes within their cytoplasm. Once a pathologist confirms the diagnosis, the medical team will use ICD-10 codes to describe the extent of the disease. While there is no specific code for the disease itself, accurate documentation is vital for insurance authorization and access to specialized care. Our DiseaseMaps.org community, which currently includes 16 members living with Rosai-Dorfman disease, often highlights the importance of working with specialists who are familiar with these coding nuances to ensure seamless care coordination.
Understanding the clinical presentation of Rosai-Dorfman disease helps in selecting the most appropriate diagnostic codes during the patient journey. The following features are commonly observed in patients:
Current research suggests that Rosai-Dorfman disease is generally not inherited. While somatic mutations, particularly in the MAPK/ERK pathway (such as KRAS, MAP2K1, or ARAF mutations), have been identified in a subset of patients, these are not typically passed down through families. Genetic counseling is often recommended for patients to clarify that Rosai-Dorfman disease is considered a sporadic condition rather than a hereditary genetic syndrome.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.